These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17073736)

  • 1. Natural post-translational modifications of chemokines.
    Proost P; Struyf S; Van Damme J
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):997-1001. PubMed ID: 17073736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic processing of chemokines: implications in physiological and pathological conditions.
    Wolf M; Albrecht S; Märki C
    Int J Biochem Cell Biol; 2008; 40(6-7):1185-98. PubMed ID: 18243768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines.
    Mortier A; Gouwy M; Van Damme J; Proost P
    Exp Cell Res; 2011 Mar; 317(5):642-54. PubMed ID: 21146523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational control of chemokines: a role for decoy receptors?
    Comerford I; Nibbs RJ
    Immunol Lett; 2005 Jan; 96(2):163-74. PubMed ID: 15585320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of chemokine activity by posttranslational modification.
    Mortier A; Van Damme J; Proost P
    Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the mechanisms regulating chemokine activity and availability.
    Mortier A; Van Damme J; Proost P
    Immunol Lett; 2012 Jul; 145(1-2):2-9. PubMed ID: 22698177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 1. Isolation, identification, and production of posttranslationally modified chemokines.
    Loos T; Mortier A; Proost P
    Methods Enzymol; 2009; 461():3-29. PubMed ID: 19480912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of chemotactic networks by 'atypical' receptors.
    Comerford I; Litchfield W; Harata-Lee Y; Nibbs RJ; McColl SR
    Bioessays; 2007 Mar; 29(3):237-47. PubMed ID: 17295321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 13. Characterizing proteolytic processing of chemokines by mass spectrometry, biochemistry, neo-epitope antibodies and functional assays.
    Starr AE; Overall CM
    Methods Enzymol; 2009; 461():281-307. PubMed ID: 19480924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors.
    Szpakowska M; Fievez V; Arumugan K; van Nuland N; Schmit JC; Chevigné A
    Biochem Pharmacol; 2012 Nov; 84(10):1366-80. PubMed ID: 22935450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuning inflammation and immunity by chemokine sequestration: decoys and more.
    Mantovani A; Bonecchi R; Locati M
    Nat Rev Immunol; 2006 Dec; 6(12):907-18. PubMed ID: 17124512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
    Zeremski M; Petrovic LM; Talal AH
    J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities.
    Ponte AL; Marais E; Gallay N; Langonné A; Delorme B; Hérault O; Charbord P; Domenech J
    Stem Cells; 2007 Jul; 25(7):1737-45. PubMed ID: 17395768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo regulation of chemokine activity by post-translational modification.
    Moelants EA; Mortier A; Van Damme J; Proost P
    Immunol Cell Biol; 2013 Jul; 91(6):402-7. PubMed ID: 23628804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of chemokines in ocular diseases. Part II. Participation of chemokines in ocular diseases].
    Malesiński R; Mrugacz M; Bakunowicz-Łazarczyk A
    Klin Oczna; 2007; 109(7-9):345-8. PubMed ID: 18260295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-encoded chemokine receptors--putative novel antiviral drug targets.
    Rosenkilde MM
    Neuropharmacology; 2005 Jan; 48(1):1-13. PubMed ID: 15617722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine and chemoattractant receptor expression: post-transcriptional regulation.
    Hamilton TA; Novotny M; Datta S; Mandal P; Hartupee J; Tebo J; Li X
    J Leukoc Biol; 2007 Aug; 82(2):213-9. PubMed ID: 17409125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.
    Richter R; Casarosa P; Ständker L; Münch J; Springael JY; Nijmeijer S; Forssmann WG; Vischer HF; Vakili J; Detheux M; Parmentier M; Leurs R; Smit MJ
    J Immunol; 2009 Jul; 183(2):1229-37. PubMed ID: 19553544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy in cytokine and chemokine networks amplifies the inflammatory response.
    Gouwy M; Struyf S; Proost P; Van Damme J
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):561-80. PubMed ID: 16023396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.